Prevention of Invasive Aspergillosis in High-Risk Patients: Universal Versus Preemptive, Targeted Treatment.

about

Prevention of Invasive Aspergillosis in High-Risk Patients: Universal Versus Preemptive, Targeted Treatment.

Item

http://www.wikidata.org/entity/Q41688288

description

2008 nî lūn-bûn

@nan

2008年の論文

@ja

2008年論文

@yue

2008年論文

@zh-hant

2008年論文

@zh-hk

2008年論文

@zh-mo

2008年論文

@zh-tw

2008年论文

@wuu

2008年论文

@zh

2008年论文

@zh-cn

name

Prevention of Invasive Aspergi ...... reemptive, Targeted Treatment.

@en

type

Item

label

Prevention of Invasive Aspergi ...... reemptive, Targeted Treatment.

@en

prefLabel

Prevention of Invasive Aspergi ...... reemptive, Targeted Treatment.

@en

P1476

Prevention of Invasive Aspergi ...... reemptive, Targeted Treatment.

@en

P2093

John W Baddley

http://www.w3.org/2001/XMLSchema#string

Senu Apewokin

http://www.w3.org/2001/XMLSchema#string

P2860

Voriconazole compared with liposomal amphotericin B for empirical antifungal therapy in patients with neutropenia and persistent fever

Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis

Beta-D-glucan as a diagnostic adjunct for invasive fungal infections: validation, cutoff development, and performance in patients with acute myelogenous leukemia and myelodysplastic syndrome

Treatment of invasive aspergillosis with posaconazole in patients who are refractory to or intolerant of conventional therapy: an externally controlled trial

Posaconazole vs. fluconazole or itraconazole prophylaxis in patients with neutropenia

Antifungal prophylaxis in cancer patients after chemotherapy or hematopoietic stem-cell transplantation: systematic review and meta-analysis.

Towards a targeted, risk-based, antifungal strategy in neutropenic patients.

2002 guidelines for the use of antimicrobial agents in neutropenic patients with cancer.

Open-label, randomized comparison of itraconazole versus caspofungin for prophylaxis in patients with hematologic malignancies.

Micafungin versus fluconazole for prophylaxis against invasive fungal infections during neutropenia in patients undergoing hematopoietic stem cell transplantation.

P2888

s12281-008-0010-6

P304

61-68

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S12281-008-0010-6

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2008-05-30T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28959373

http://www.w3.org/2001/XMLSchema#string

P921

aspergillosis

P932

5614449

http://www.w3.org/2001/XMLSchema#string